Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Ann Epidemiol. 2014 May 22;24(8):581–587. doi: 10.1016/j.annepidem.2014.05.007

Table 3.

Coronary heart disease incidence and mortality rates and adjusted hazard ratios (95% CI) for the association of time period with CHD incidence and mortality in 1987–1996 and 2003–2009, stratified by diabetes status

No Diabetes Diabetes p-value interaction
1987–1996 2003–2009 1987–1996 2003–2009
N 13,152 10,415 1,673 2,297
CHD incidence
 Incidence rate* (95% CI) 3.9 (3.5, 4.4) 2.2 (1.8, 2.7) 11.1 (9.3, 13.2) 5.4 (4.2, 7.0) ---
 Model 1 1 (ref) 0.60 (0.48, 0.76) 1 (ref) 0.53 (0.38, 0.73) 0.39
 Model 2 1 (ref) 0.64 (0.50, 0.80) 1 (ref) 0.56 (0.40, 0.78) 0.33
 Model 3§ 1 (ref) 0.75 (0.59, 0.96) 1 (ref) 0.68 (0.46, 0.99) 0.95
CHD mortality
 Mortality rate* (95% CI) 0.8 (0.7, 1.1) 0.4 (0.3, 0.6) 4.3 (3.2, 5.7) 1.3 (0.9, 1.9) ---
 Model 1 1 (ref) 0.49 (0.32, 0.76) 1 (ref) 0.32 (0.20, 0.52) 0.09
 Model 2 1 (ref) 0.55 (0.36, 0.85) 1 (ref) 0.34 (0.20, 0.56) 0.08
 Model 3§ 1 (ref) 0.64 (0.40, 1.00) 1 (ref) 0.45 (0.26, 0.80) 0.21

CHD: coronary heart disease; CI: confidence interval; p-value for interaction of diabetes status and time period

*

Rates are per 1,000 person-years and adjusted for age, race, and sex

Model 1: adjusted for age, race, and sex

Model 2: adjusted for age, race, sex, high-density lipoprotein cholesterol, systolic blood pressure, antihypertensive medication use, current smoking, and body mass index

§

Model 3: adjusted for model 2 variables plus lipid-lowering medication use and low-density lipoprotein cholesterol